CAEDO ONCOLOGY AS
926135082ActiveDeveloping novel monoclonal antibodies for targeted cancer immunotherapy treatment.
Biotechnology Companycaedooncology.com
Yleiskatsaus
- Tuntematon
- Työntekijät
- 0 NOK
- Liikevaihto
- 2020
- Perustettu
Avainpäättäjät
Kjetil Hestdal
Co-founder and CEO
Ole J. Dahlberg
Board member
Torbjørn Øye
CFO
Rolf D. Pettersen
Co-founder and Scientific Advisor/Board Member
+7 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Caedo Oncology is a biotechnology company established in November 2020, focused on revolutionizing cancer treatment through novel immunotherapy. Their core mission is to develop improved treatment options by creating proprietary monoclonal antibodies that induce programmed cell death in cancer cells...
BioInvent International Aktiebolag